APA

Koziolek E. J., Donoghue J. F., Bentley J. D., Lovrecz G., Dolezal O., Ward C. W., Rothacker J., Nice E. C., Burgess A. W., Hafner M., Johns T. G. & Adams T. E. (20130404). A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation. : Growth factors (Chur, Switzerland).

Chicago

Koziolek Eva J, Donoghue Jacqueline F, Bentley John D, Lovrecz George, Dolezal Olan, Ward Colin W, Rothacker Julie, Nice Edouard C, Burgess Antony W, Hafner M, Johns Terrance G and Adams Timothy E. 20130404. A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation. : Growth factors (Chur, Switzerland).

Harvard

Koziolek E. J., Donoghue J. F., Bentley J. D., Lovrecz G., Dolezal O., Ward C. W., Rothacker J., Nice E. C., Burgess A. W., Hafner M., Johns T. G. and Adams T. E. (20130404). A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation. : Growth factors (Chur, Switzerland).

MLA

Koziolek Eva J, Donoghue Jacqueline F, Bentley John D, Lovrecz George, Dolezal Olan, Ward Colin W, Rothacker Julie, Nice Edouard C, Burgess Antony W, Hafner M, Johns Terrance G and Adams Timothy E. A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation. : Growth factors (Chur, Switzerland). 20130404.